STATEMENT OF STATUTORY AUTHORITY, BASIS AND PURPOSE:
The statutory authority for the adoption of rules is C.R.S. 12-60-503(1). The basis and purpose for the adoption of amended rule #3.602 of Colorado Racing Commission Rules is to further define the requirements to obtain a jockey or apprentice jockey license for competence and safety for all similar licensed participants in flat racing as published in the Association of Racing Commissioners (ARCI) Model Rules document which is recognized as an industry standard by the Colorado Racing Commission.  
AMENDED RULE
3.602 - An applicant for a jockey or apprentice jockey license SHALL SHOW COMPETENCE BY PRIOR LICENSING AS APPROVED BY THE STEWARDS, AND/OR THE DEMONSTRATION OF RIDING ABILITY, WHICH MAY INCLUDE PARTICIPATION IN UP TO FIVE RACES WITH THE PRIOR APPROVAL OF THE STEWARDS WITH THE CONSIDERATION OF THE RECOMMENDATIONS FROM THE STARTER, THE HEAD OUTRIDER, AND THE DESIGNATED REPRESENTATIVES OF THE JOCKEYS AND THE HORSEMEN AT THE TRACK.  THE DEMONSTRATION OF RIDING ABILITY IS DEFINED AT A MINIMUM OF:
(a)	BREAKING A HORSE IN COMPANY FROM THE STARTING GATE;
(b)	WORKING A HORSE IN COMPANY AROUND THE TURN AND DOWN THE STRETCH;
(c)	SWITCHING THE RIDING WHIP FROM ONE HAND TO THE OTHER WHILE MAINTAINING CONTROL OF THE HORSE IN A STRETCH DRIVE; AND
(d)	CAUSING AIDING A HORSE TO SWITCH LEADS COMING OUT OF A TURN.

STATEMENT OF STATUTORY AUTHORITY, BASIS AND PURPOSE:
The statutory authority for the adoption of rules is C.R.S. 12-60-503(1). The basis and purpose for the adoption of amended rule #5.300 of Colorado Racing Commission Rules is to move the classification for Anabolic and/or Androgenic Steroids from a Class IV medication to a Class III medication as published in the Association of Racing Commissioners (ARCI) Model Rules publication which is recognized as an industry standard by the Colorado Racing Commission for unauthorized medication.  

AMENDED RULE
5.300 – The following outline describes the types of substances placed in each category. This list shall be publicly posted in the offices of the Division veterinarian and the racing secretary.
1:  Class 1

Opiates, opium derivatives, synthetic opioids, psychoactive drugs, amphetamines and U.S. Drug Enforcement Agency (DEA) scheduled I and II drugs. Also found in this Class are drugs which are potent stimulants of the nervous system. Drugs in this Class have no generally accepted medical use in the racehorse and their pharmacological potential for altering the performance of a race is very high.
2:  Class 2
Drugs in this category have a high potential for affecting the outcome of a race. Most are not generally accepted as therapeutic agents in the racehorse. Many are products intended to alter consciousness or the psychic state of humans, and have no approved or indicated use in the horse. Some, such as injectable local anesthetics, have legitimate use in equine medicine, but should not be found in a racehorse. The following groups of drugs are in this class:
(A)	Opiate partial agonists, or agonist-antagonists;
(B) Non-opiate psychotropic drugs, which may have stimulant, depressant, analgesic or neuroleptic effects;
(C) Miscellaneous drugs which might have a stimulant effect on the central nervous system (CNS);
(D) Drugs with prominent CNS depressant action;
(E) Antidepressant and antipsychotic drugs, with or without prominent CNS stimulatory or depressant effects;
(F)	Muscle blocking drugs which have a direct neuromuscular blocking action;
(G)	Local anesthetics which have a reasonable potential for use as nerve blocking agents (except Procaine); and
(H)	Snake venoms and other biologic substances, which may be used as nerve blocking agents.
3:  Class 3
Drugs in this Class may or may not have an accepted therapeutic use in the horse. Many are drugs that affect the cardiovascular, pulmonary and autonomic nervous systems. They all have the potential of affecting the performance of a racehorse. The following groups of drugs are in this Class:
(A)	Drugs affecting the autonomic nervous system which do not have prominent CNS effects, but which do have prominent cardiovascular or respiratory system effects (Bronchodilators are included in this Class);
(B)	A local anesthetic which has nerve blocking potential but also has a high potential for producing urine residue levels from a method of use not related to the anesthetic effect of the drug (Procaine);
(C)	Miscellaneous drugs with mild sedative action, such as the sleep inducing antihistamines;
(D)	Primary vasodilating/hypotensive agents; and
(E)	Potent diuretics affecting renal function and body fluid composition.
(F)	ANABOLIC AND/OR ANDROGENIC STEROIDS;
4:   Class 4
This category is comprised primarily of therapeutic medications routinely used in racehorses.  These may influence performance, but generally have a more limited ability to do so. Groups of drugs assigned to this category include the following:
(A)	Non-opiate drugs which have a mild central analgesic effect;
(B)	Drugs affecting the autonomic nervous system which do not have prominent CNS, cardiovascular or respiratory effects;
                                      (I)  Drugs used solely as topical vasoconstrictors or decongestants
                                      (II)   Drugs used as gastrointestinal antispasmodics
                                      (III)  Drugs used to void the urinary bladder

(IV) Drugs with a major effect on CNS vasculature or smooth muscle of              visceral organs.

(V) Antihistamines which do not have a significant CNS depressant
effect (This does  not include H1 blocking agents, which are listed in Class 5);
(C)	Mineralocorticoid drugs;
(D) Skeletal muscle relaxants;
(E) Anti-inflammatory drugs—Those that may reduce pain as a consequence of
      their anti-inflammatory actions, which include:
   (I) Non-steroidal anti-inflammatory drugs (NSAIDS);
   (II) Corticosteroids (Glucocorticoids); and
   (III) Miscellaneous anti-inflammatory agents.
(F) Anabolic and/or androgenic steroids and other drugs;
(G)(F) Less potent diuretics;
(H)(G)Cardiac glycosides and antiarrhythmics including:
   (I)   Cardiac glycosides;
(II) Antiarrhythmic agents (exclusive of Lidocaine, Bretylium and
      Propanolol); and
   (III) Miscellaneous cardiotonic drugs.
(I)(H) Topical anesthetics—Agents not available in injectable formulations;
(J)(I)  Antidiarrheal agents; and
(K)(J) Miscellaneous drugs including:
   (I) Expectorants with little or no other pharmacologic action;
   (II) Stomachics; and
   (III) Mucolytic agents.
5:  Class 5
Drugs in this category are therapeutic medications for which concentration limits have been established as well as certain miscellaneous agents. Included specifically are agents which have very localized action only, such as anti-ulcer drugs and certain antiallergenic drugs. The anticoagulant drugs are also included.

STATEMENT OF STATUTORY AUTHORITY, BASIS AND PURPOSE:
The statutory authority for the adoption of rules is C.R.S. 12-60-503(1). The basis and purpose for the adoption of amended rule #5.331 of Colorado Racing Commission Rules is to further clarify and define the presence of Androgenic-Anabolic Steroids in animals and the reporting protocol for male horses to the testing labs as published in the Association of Racing Commissioners (ARCI) Model Rules document which is recognized as an industry standard by the Colorado Racing Commission.  

AMENDED RULE
5.331 -  Androgenic-Anabolic Steroids (AAS) 

(1)  No AAS shall be permitted in test samples collected from racing horses, except for residues of the major metabolite of Stanozolol, Nandrolone, and the naturally occurring substances, Boldenone and Testosterone, at concentrations less than the indicated thresholds. 
(2) Concentrations of these AAS shall not exceed the following urine threshold concentrations for total drug (i.e., free drug or metabolite and drug or metabolite liberated from its conjugates):
(a)  	16β-hydroxystanozolol (metabolite of Stanozolol (Winstrol®)) – 1 ng/ml in urine for all horses regardless of sex;
(b)	Boldenone (Equipoise® is the undecylenate ester of Boldenone)  in male horses other than geldings --- 15 ng/ml in urine.  No Boldenone shall be permitted in geldings or female horses.
(c)	Nandrolone (Durabolin® is the phenylpropionate ester and deca-durabolin® is the decanoate ester) – 
1.	In geldings --- 1 ng/ml in urine
2.	In fillies and mares --- 1 ng/ml in urine.
3.	In male horses other than geldings --- 45 ng/ml in urine
      	 (d)  	Testosterone 
1.	In geldings –-- 20 ng/ml in urine
2.	In fillies and mares –-- 55 ng/ml in urine
3.	In male horses other than geldings minimum thresholds will not apply
(3)  All other AAS are prohibited in racing horses.
        (4)  The presence of more than one of the four AAS identified in (2) above at concentrations greater than the individual thresholds indicated above shall not be permitted.
(5)(4)  Post-race urine samples MUST HAVE THE SEX OF THE HORSE collected from intact males must be identified to the laboratory. 
(6)(5)  Any horse to which an anabolic steroid  has been administered in order to assist in the recovery from illness or injury may be placed on the veterinarian’s list in order to monitor the concentration of the drug or metabolite in urine.  After the concentration has fallen below the designated threshold for the administered AAS, the horse is eligible to be removed from the list.  Any laboratory testing to determine the concentration of an administered AAS shall be done at the trainer’s and/or the owner’s sole expense.

STATEMENT OF STATUTORY AUTHORITY, BASIS AND PURPOSE:
The statutory authority for the adoption of rules is C.R.S. 12-60-503(1). The basis and purpose for the adoption of amended rule 5.440 of Colorado Racing Commission Rules is to amend the interpretation of mitigating circumstances concerning the presence of an unauthorized drug or medication in an animal is confirmed in a race that the Board or Hearing Officer may consider in deliberations of violations of the medication rules.  

AMENDED RULE
5.440 – Upon a finding of a violation of these medication and prohibited substances rules, the stewards or hearing officer shall consider the classification level of the violation as listed in at the time of the violation in the Uniform Classification Guidelines of Foreign Substances as promulgated by the Association of Racing Commissioners International and impose penalties and disciplinary measures consistent with the recommendations contained therein. The Board or hearing officer shall MAY also consult with the Division veterinarian to determine the nature and seriousness of the laboratory finding or the medication violation and if the violation was a result of the administration of a therapeutic medication as documented in a veterinarian’s report received per rule #5.236. Provided, however, that in the event that the hearing officer or a majority of the Board determine that mitigating circumstances require imposition of a lesser penalty, they may impose the lesser penalty. In the event that the hearing officer or a majority of the Board wish to impose a greater penalty or a penalty in excess of the authority granted them, then, and in such event, they may impose the maximum penalty authorized and refer the matter to the Commission with specific recommendations for further action.  In determining if there are mitigating circumstances surrounding a medication violation for substances, the Board or hearing officer shall MAY consider, at least BUT NOT LIMITED TO the following:	
1.	The past record of the trainer in drug cases;
2.   The potential of the drug(s) to influence a horse’s racing performance;
3.   The availability of the drug;
2.	Whether there is reason to believe the responsible party knew of the administration of the drug use:
3.	The steps taken by the trainer to safeguard the horse;
4.	The probability of environmental contamination or inadvertent exposure due to human drug use;
5.	The purse of the race;
6.	Whether the drug found was one for which the horse was receiving a treatment as determined by the veterinarian report(s), and;
7.	Whether there was any suspicious betting pattern in the race.

STATEMENT OF STATUTORY AUTHORITY, BASIS AND PURPOSE:
The statutory authority for the adoption of rules is C.R.S. 12-60-503(1). The basis and purpose for the adoption of amended rule #5.502 of Colorado Racing Commission Rules is to further restrict the presence of an unauthorized drug or medication and its effect on the performance of an animal in a race as interpreted by the Colorado Racing Commission, July 2008.  

Amended Rule
5.502 - The trainer shall be responsible for and the absolute insurer of the condition of the animals entered for his or HER kennel/stable regardless of the acts of third parties except as provided in these rules.  If the chemical analysis of a sample indicates the presence of an unauthorized drug OR MEDICATION REGARDLESS OF THE which could Effect the ON THE racing condition or the performance of an animal in a race, the trainer of the animal and any other person shown to have care or attendance of the animal or shown to have administered or conspired to have administered the drug are subject to disciplinary action. The owner of the animal shall not participate in the purse distribution of that race, a redistribution of that purse shall be ordered, and the animal shall be declared unplaced for every purpose except for pari-mutuel wagering and the grading system as it pertains to greyhound racing. A trophy received by the owner of the animal shall be returned.

STATEMENT OF STATUTORY AUTHORITY, BASIS AND PURPOSE:
The statutory authority for the adoption of rules is C.R.S. 12-60-503(1). The basis and purpose for the adoption of amended rule #7.218 of Colorado Racing Commission Rules is to allow a jockey that has been taken off his/her accepted and scheduled mount to be compensated an amount equal to the fee that the jockey earned who rode the horse by the licensed owner.
Amended Rule
7.218 - If the owner, trainer or authorized agent, engages more than one jockey for the same race after the time designated by the racing secretary to name jockeys, the owner shall pay the jockey taken off the horse a jockey mount fee that is equivalent to the minimum jockey mount fee paid TO THE JOCKEY OF THE HORSE IN THAT for the particular race.  A jockey shall not be engaged for the purpose of preventing the ANOTHER jockey from riding in a race. Notwithstanding the foregoing, a jockey mount fee is not earned by a jockey when a jockey or his or her agent elects to take himself or herself off a mount or when the stewards replace the jockey with a substitute jockey for reasons other than the jockey suffering an injury during the time between weighing-out and the start of the race.
STATEMENT OF STATUTORY AUTHORITY, BASIS AND PURPOSE:
The statutory authority for the adoption of rules is C.R.S. 12-60-503(1). The basis and purpose for the adoption of amended rule #7.646 of Colorado Racing Commission Rules is to further define the equipment that shall not be used to establish the riding weight for jockeys as published in the Association of Racing Commissioners (ARCI) Model Rules document which is recognized as an industry standard by the Colorado Racing Commission.   
Amended Rule
7.646 - The jockey’s weight shall also include clothing, NUMBER CLOTH, boots, saddle and attachments AND ANY OTHER EQUIPMENT EXCEPT THE NUMBER CLOTH, WHIP, BRIDLE, BIT, BLINKERS, GOGGLES AND SAFETY EQUIPMENT INCLUDING HELMET, VEST, OVER-GIRTH, REINS AND BREAST COLLAR.

STATEMENT OF STATUTORY AUTHORITY, BASIS AND PURPOSE:
The statutory authority for the adoption of rules is C.R.S. 12-60-503(1). The basis and purpose for the adoption of amended rule 8.400 of Colorado Racing Commission Rules is to allow the association to write and allow entries into races, which have the option of different eligibility conditions to include different claiming prices for horses, which will allow more horses to be eligible to enter to race for different types of conditions for the same race. 
Amended Rule
8.400 – AN OptionAL claiming races are not permitted on any racetrack under the jurisdiction of the Commission. IS A CONTEST IN WHICH SELECTED HORSES ARE ENTERED TO BE CLAIMED FOR A STATED CLAIMING PRICE.  IN THE CASE OF HORSES ENTERED TO BE CLAIMED IN SUCH A RACE, THE RACE SHALL BE CONSIDERED, FOR THE PURPOSE OF THESE RULES, A CLAIMING RACE.  IN THE CASE OF HORSES ENTERED NOT ENTERED TO BE CLAIMED, THE RACE SHALL BE CONSIDERED AN ALLOWANCE RACE.

STATEMENT OF STATUTORY AUTHORITY, BASIS AND PURPOSE:
The statutory authority for the adoption of rules is C.R.S. 12-60-503(1). The basis and purpose for the adoption of amended rule 12.184 of Colorado Racing Commission Rules is to allow the creation of the outs book electronically and to allow the ability to modify and/or waive the requirement of a Division representative being present due to the location of the totalisator system at the time of printing.  
Amended Rule
12.184 – A Division representative must be present at the time of printing OR ELECTRONIC CREATION.  THE DIVISION MAY MODIFY AND/OR WAIVE THIS REQUIREMENT WHEN THE TOTALISATOR SYSTEM LOCATION THAT CONTAINS THE OUTS BOOK INFORMATION IS LOCATED OUT OF STATE.  

STATEMENT OF STATUTORY AUTHORITY, BASIS AND PURPOSE:
The statutory authority for the adoption of rules is C.R.S. 12-60-503(1). The basis and purpose for the adoption of amended rule 12.186 of Colorado Racing Commission Rules is to allow the creation of the outs book on electronic media without the written approval of the Commission. 
Amended Rule
12.186- No subsequent sets of outs books may be printed OR ELECTRONICALLY CREATED without written approval of the Commission.

STATEMENT OF STATUTORY AUTHORITY, BASIS AND PURPOSE:
The statutory authority for the adoption of rules is C.R.S. 12-60-503(1). The basis and purpose for the adoption of amended rule 12.198 of Colorado Racing Commission Rules is to ensure that all electronic media that is created concerning outstanding ticket records and files are properly secured pursuant to this rule.

Amended Rule
12.198 - At all times an association shall insure the security of purged tickets and the integrity of the outstanding ticket records and files INCLUDING ELECTRONIC MEDIA. Such security measures shall include but not be limited to:
	:1 - access by tote employees to purged ticket storage areas shall be prohibited;
	:2 - purged tickets shall be maintained in a two‑hour fire resistant enclosure;
	:3 - the purged ticket enclosure shall be secured by a separate locking system;
:4 - only the mutuel manager or designee shall have access to purged ticket storage facilities; 
:5 - access to the magnetic tape logs or comparable mediums and tote library tapes by the mutuel manager or staff shall be prohibited; and
:6 - possession of the magnetic tape logs and library tapes shall be retained by the association for a period of two (2) years from the end of the race meet.